Giorgia Peverelli

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.

Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.

Journal: Clinical breast cancer

Published: July 22, 2022

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.

Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.

Journal: Frontiers in oncology

Published: May 11, 2022

Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.

Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.

Journal: Therapeutic advances in medical oncology

Published: June 19, 2020

Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori.

Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori.

Journal: Tumori

Published: March 03, 2020

Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.

Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer.

Journal: Cancers

Published: February 05, 2020

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 19, 2019

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.

Journal: International journal of cancer

Published: May 29, 2019

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.

Journal: Scientific reports

Published: October 24, 2018

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program.

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program.

Journal: American journal of clinical oncology

Published: September 12, 2018

Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population.

Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World Population.

Journal: Clinical genitourinary cancer

Published: August 29, 2018

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Journal: Targeted oncology

Published: August 04, 2018

Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.

Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategies.

Journal: Pharmacogenomics

Published: July 26, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026